Bruce G. Allen Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.3K Buy
2,217
+398
+22% +$10.6K 0.04% 225
2025
Q4
$45.3K Buy
1,819
+35
+2% +$883 0.03% 269
2025
Q3
$45.5K Buy
1,784
+118
+7% +$2.91K 0.03% 273
2025
Q2
$40.4K Sell
1,666
-467
-22% -$10.9K 0.03% 288
2025
Q1
$54K Sell
2,133
-1,073
-33% -$28.1K 0.04% 235
2024
Q4
$85.1K Sell
3,206
-4,014
-56% -$109K 0.07% 166
2024
Q3
$209K Sell
7,220
-1,224
-14% -$35.7K 0.16% 74
2024
Q2
$236K Buy
8,444
+1,502
+22% +$41.4K 0.2% 65
2024
Q1
$193K Buy
6,942
+811
+13% +$22.5K 0.16% 80
2023
Q4
$177K Buy
+6,131
New +$185K 0.16% 84

Other funds holding PFE

Bruce G. Allen Investments's PFE Position: Q1 2026 in Review

Bruce G. Allen Investments increased its Pfizer (PFE) stake by 22% in Q1 2026, buying an estimated $10.6K and bringing the position to 2,217 shares worth $62.3K. The position accounts for 0.04% of the portfolio, ranked #225.

Bruce G. Allen Investments first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $236K in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bruce G. Allen Investments held 2,217 shares of Pfizer worth $62.3K as of Q1 2026.
  • Bruce G. Allen Investments bought 398 Pfizer shares in Q1 2026, an estimated $10.6K.
  • Pfizer made up 0.04% of Bruce G. Allen Investments's portfolio in Q1 2026, its #225 holding.
  • Bruce G. Allen Investments first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Bruce G. Allen Investments's Pfizer position peaked at $236K in Q2 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.